Duolingo's stock jumps 10% after learning platform swings to surprise Q3 profit
Shares of Duolingo Inc. (DUOL) rallied more than 10% in the extended session Wednesday after the language-learning platform swung to an unexpected third-quarter profit and its revenue jumped 43%. Duolingo earned $2.8 million, or 6 cents a share, in the quarter, compared with a loss of $18.5 million, or 46 cents a share, in the year-ago period. Revenue rose 43% to $138 million, Duolingo said. Analysts polled by FactSet expected the company to report a loss of 7 cents a share on sales of $132 million. Duolingo said it had 83.1 million monthly active users, an increase of 47% from the prior-year quarter. The company last month announced a strategic shift toward becoming a multi-subject product, rather than just languages, and started offering math and music courses on its app. "We believe this offers great value to our users, and can unlock benefit to us over time as we can apply the things that make our language app fun, engaging, and effective to these new courses," Chief Executive and co-founder Luis von Ahn said in a statement.
-Claudia Assis
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-08-23 1617ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Boeing Stock a Buy, a Sell, or Fairly Valued?